GeneLink Inc. 

(Public, OTC:GNLK)   Watch this stock   
Find more results for GNLK

Key stats and ratios

Q2 (Jun '09) 2008
Net profit margin -38.81% -40.87%
Operating margin -37.01% -39.97%
EBITD margin - -38.61%
Return on average assets -131.82% -132.65%
Return on average equity -2885.10% -2110.12%
Employees 15 -

Address

317 Wekiva Spring Road Suite 200
Longwood, FL 32779
United States - Map
+1-800-5584363 (Phone)
+1-800-5584363 (Fax)

Website links

GeneLink Inc. discussions

  View all discussions »

Description

GeneLink, Inc.( GeneLink) has created a methodology for single nucleotide polymorphism (SNP) based genetic profiling and focuses to market and/or out-license these assessments to companies that manufacture or market to the nutraceutical, personal care, skin care and weight-loss industries. The Company has developed SNP-based genetic profiles (named GeneLink Nutragenetic Profile and Dermagenetics profiles). These profiles provide a means of predicting an individual's inherent genetic capacity to combat such conditions as oxidative stress and other important selected areas of physiologic health.

Officers and directors

Bernard L. Kasten Jr., M.D.
Executive Chairman of the Board
Age: 62
Monte E. Taylor Jr.
Chief Executive Officer, Chief Financial Officer, Director
Age: 59
John H. Souza
Chief Operating Officer, Director
Age: 47
Robert P. Ricciardi Ph.D.
Chief Scientific Officer, Secretary, Director
Age: 62
Robert Hoekstra
Director
Age: 58
James Monton
Director
Age: 63
Douglas M. Boyle CPA
Director